MEI Pharma Statistics

Total Valuation

MEI Pharma has a market cap or net worth of $14.23 million. The enterprise value is -$9.38 million.

Market Cap	14.23M
Enterprise Value	-9.38M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

MEI Pharma has 6.66 million shares outstanding.

Current Share Class	6.66M
Shares Outstanding	6.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	16.03%
Float	4.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.65
P/TBV Ratio	0.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.66

Current Ratio	10.66
Quick Ratio	10.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -93.69% and return on invested capital (ROIC) is -33.73%.

Return on Equity (ROE)	-93.69%
Return on Assets (ROA)	-30.67%
Return on Invested Capital (ROIC)	-33.73%
Return on Capital Employed (ROCE)	-114.30%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.92% in the last 52 weeks. The beta is 0.61, so MEI Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-35.92%
50-Day Moving Average	2.30
200-Day Moving Average	2.77
Relative Strength Index (RSI)	53.52
Average Volume (20 Days)	12,096

Short Selling Information

The latest short interest is 2,627, so 0.04% of the outstanding shares have been sold short.

Short Interest	2,627
Short Previous Month	3,543
Short % of Shares Out	0.04%
Short % of Float	0.05%
Short Ratio (days to cover)	0.29

Income Statement

Revenue	n/a
Gross Profit	-10.86M
Operating Income	-25.26M
Pretax Income	26.16M
Net Income	-38.22M
EBITDA	-24.68M
EBIT	-25.26M
Earnings Per Share (EPS)	-$5.74

Full Income Statement

Balance Sheet

The company has $23.74 million in cash and n/a in debt, giving a net cash position of $23.74 million or $3.56 per share.

Cash & Cash Equivalents	23.74M
Total Debt	n/a
Net Cash	23.74M
Net Cash Per Share	$3.56
Equity (Book Value)	22.10M
Book Value Per Share	3.32
Working Capital	22.10M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-36.04M
Capital Expenditures	n/a
Free Cash Flow	-36.04M
FCF Per Share	-$5.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MEI Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-266.16%
FCF Yield	-251.02%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 17, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 17, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

MEI Pharma has an Altman Z-Score of -19.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.32
Piotroski F-Score	2